6-Thioinosine

HCID 676166CAS 4988-64-1

Grundinformationen

Standard-SMILES
OC[C@H]1O[C@@H](n2cnc3c(=S)nc[nH]c32)[C@H](O)[C@@H]1O
InChIKey
NKGPJODWTZCHGF-KQYNXXCUSA-N
Summenformel
C10H12N4O4S
Durchschnittliche Molmasse
284,29 g/mol

Überblick

Thioinosine is a sulfhydryl analog of inosine and an antimetabolite with potential antineoplastic and immunosuppressive properties. Thioinosine interferes with de novo purine synthesis and perturbs the pool of nucleotides necessary for DNA replication. As a result, this agent inhibits DNA synthesis, blocks cellular proliferation and induces apoptosis.

Namen und Bezeichner

Bevorzugter Name
6-Thioinosine
IUPAC
9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H-purine-6-thione

Namen und Synonyme

574-25-46-ThioinosineTHIOINOSINERibosyl-6-thiopurineMercaptopurine ribonucleosideMercaptopurine riboside6-Mercaptopurine ribonucleoside6H-Purine-6-thione, 1,9-dihydro-9-ribofuranosyl-9H-Purine-6(1H)-thione, 9-beta-D-ribofuranosyl-46S541971TRibosyl-6-mercaptopurineRibosyl 6 mercaptopurine
Weitere Namen anzeigen
6 Mercaptopurine RibosideRiboside, 6-MercaptopurineNSC4911inosine, 6-thioRefChem:189543DTXCID301478415209-371-5DTXSID5046019

Datenbank-Bezeichner

CAS
4988-64-1、574-25-4
PubChem CID
676166
ChEMBL
CHEMBL448290
UNII
46S541971T
EC Number
209-371-5
Nikkaji
J33.135J

Eigenschaften

Berechnete Struktureigenschaften

XLogP
-0,6
Polarare Oberfläche (TPSA)
144 Ų
H-Brücken-Donoren
4
H-Brücken-Akzeptoren
6
Frei drehbare Bindungen
2
Schwere Atome
19

Experimentelle und physikochemische Eigenschaften

LogP-0.6

Sicherheit und Regulatorisches

GHS-Klassifizierung

GHS Classification · 4 Einträge

Warning

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 39 reports by companies from 1 notifications to the ECHA C&L Inventory.

Gefahrenhinweise

Hazard Classes and CategoriesAcute Tox. 4 (100%)

Chemie und Industrie

Pharmakologische Informationen

MeSH Pharmacological Classification · 2 Einträge

Antimetabolites that are useful in cancer chemotherapy.

Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging.

Tissue LocationsKidney
Cellular LocationsCytoplasm
Metabolite PathwaysAzathioprine Action Pathway

Zugehörige Reaktionen

4

Verknüpfte Notizen

Wird geladen…